Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029029 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00029029: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00029029 is a Phase 2 study that has completed, run by Mayo Clinic. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00029029, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells and may help to relieve pain caused by bone metastases. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in relieving pain in patients who have bone metastases.
Interventions
- PROCEDURE pain therapy
- PROCEDURE radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-10-13 |
| Est. Completion | 2002-10-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029029
The ClinicalTrials.gov registry entry for NCT00029029 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pain therapy is the first listed.
NCT00029029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029029 about?
NCT00029029 is a clinical study titled "Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases". RATIONALE: Radiofrequency ablation uses high-frequency electric current to kill tumor cells and may help to relieve pain caused by bone metastases. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation in relieving pain in patients who have bone metastases.
What is the current status of trial NCT00029029?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-10-13. Estimated completion is 2002-10-24.
What interventions are being tested in trial NCT00029029?
The interventions under investigation include: pain therapy (PROCEDURE), radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT00029029?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.